Huntington National Bank’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $129 | Hold |
1
| – | – | ﹤0.01% | 2564 |
|
|
2025
Q4 | $129 | Hold |
1
| – | – | ﹤0.01% | 2486 |
|
|
2025
Q3 | $129 | Sell |
1
-210
| -100% | -$27.1K | ﹤0.01% | 2581 |
|
|
2025
Q2 | $27K | Sell |
211
-36
| -15% | -$3.74K | ﹤0.01% | 1466 |
|
|
2025
Q1 | $21.9K | Sell |
247
-49
| -17% | -$4.78K | ﹤0.01% | 1489 |
|
|
2024
Q4 | $25.8K | Buy |
296
+66
| +29% | +$6.04K | ﹤0.01% | 1464 |
|
|
2024
Q3 | $21.3K | Buy |
230
+53
| +30% | +$5.26K | ﹤0.01% | 1492 |
|
|
2024
Q2 | $19.1K | Sell |
177
-113
| -39% | -$11.3K | ﹤0.01% | 1473 |
|
|
2024
Q1 | $27.5K | Buy |
290
+6
| +2% | +$515 | ﹤0.01% | 1359 |
|
|
2023
Q4 | $26.2K | Sell |
284
-87
| -23% | -$5.64K | ﹤0.01% | 1338 |
|
|
2023
Q3 | $18.6K | Buy |
371
+107
| +41% | +$5.72K | ﹤0.01% | 1370 |
|
|
2023
Q2 | $16.7K | Sell |
264
-11
| -4% | -$598 | ﹤0.01% | 1421 |
|
|
2023
Q1 | $12.4K | Sell |
275
-10
| -4% | -$450 | ﹤0.01% | 1466 |
|
|
2022
Q4 | $12.5K | Buy |
285
+111
| +64% | +$5.32K | ﹤0.01% | 1430 |
|
|
2022
Q3 | $11K | Hold |
174
| – | – | ﹤0.01% | 1489 |
|
|
2022
Q2 | $9K | Hold |
174
| – | – | ﹤0.01% | 1592 |
|
|
2022
Q1 | $11K | Buy |
174
+12
| +7% | +$861 | ﹤0.01% | 1541 |
|
|
2021
Q4 | $17K | Sell |
162
-89
| -35% | -$9.31K | ﹤0.01% | 1423 |
|
|
2021
Q3 | $26K | Sell |
251
-78
| -24% | -$7.26K | ﹤0.01% | 1148 |
|
|
2021
Q2 | $29K | Buy |
329
+112
| +52% | +$10.3K | ﹤0.01% | 1097 |
|
|
2021
Q1 | $21K | Buy |
217
+23
| +12% | +$2.3K | ﹤0.01% | 1114 |
|
|
2020
Q4 | $22K | Sell |
194
-75
| -28% | -$7.9K | ﹤0.01% | 1085 |
|
|
2020
Q3 | $25K | Buy |
269
+17
| +7% | +$1.31K | ﹤0.01% | 965 |
|
|
2020
Q2 | $20K | Buy |
+252
| New | +$17K | ﹤0.01% | 1025 |
|
Other funds holding BPMC
Huntington National Bank's BPMC Position: Q1 2026 in Review
Huntington National Bank held its Blueprint Medicines (BPMC) position steady in Q1 2026 at 1 share worth $129. The position accounts for ﹤0.01% of the portfolio, ranked #2564.
Huntington National Bank first reported a position in BPMC in Q2 2020 and has held it in 24 quarters since. The position peaked at $29K in Q2 2021. 2 funds tracked by Wall St. Rank hold BPMC as of Q1 2026.
- Huntington National Bank held 1 share of Blueprint Medicines worth $129 as of Q1 2026.
- Huntington National Bank left its Blueprint Medicines share count unchanged in Q1 2026.
- Blueprint Medicines made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #2564 holding.
- Huntington National Bank first reported a position in Blueprint Medicines in Q2 2020 and has held it in 24 quarters since.
- Huntington National Bank's Blueprint Medicines position peaked at $29K in Q2 2021.
- 2 funds tracked by Wall St. Rank held Blueprint Medicines as of Q1 2026.
Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.